Document is current
Any future updates will be listed below
-
Authors
Boila, Liberalis Debraj
Ghosh, Subhadeep
Bandyopadhyay, Subham K.
Jin, Liqing
Murison, Alex
Zeng, Andy G. X.
Shaikh, Wasim
Bhowmik, Satyaki
Muddineni, Siva Sai Naga Anurag
Biswas, Mayukh
Sinha, Sayantani
Chatterjee, Shankha Subhra
Mbong, Nathan
Gan, Olga I.
Bose, Anwesha
Chakraborty, Sayan
Arruda, Andrea
Kennedy, James A.
Mitchell, Amanda
Lechman, Eric R.
Banerjee, Debasis
Milyavsky, Michael https://orcid.org/0000-0002-5083-0809
Minden, Mark D.
Dick, John E.
Sengupta, Amitava https://orcid.org/0000-0002-2804-1774
-
Funding
Funding for this research was provided by:
Israel Science Foundation (ISF 1512/14)
TAU | Varda and Boaz Dotan Research Center for Hemato-Oncology Research, Tel Aviv University (RCDA 14-171)
Canadian Cancer Society Research Institute (703212)
Council of Scientific and Industrial Research (HCP-0008, HCP-23 and P07/MLP-AS/578)
Department of Biotechnology, Ministry of Science and Technology (BT/PR13023/MED/31/311/2015, BT/RLF/RE-ENTRY/06/2010)
DST | Science and Engineering Research Board (SB/SO/HS-053/2013)
Indian Council of Medical Research (INDO/FRC/452/S-11/2019-20-lHD)
- License Information
-
More Information
Article History
Received: 14 September 2022
Revised: 18 January 2023
Accepted: 23 January 2023
First Online: 31 January 2023
Competing interests
: JED Celgene: Research Funding; Trillium Therapeutics/Pfizer: patents for Sirp-a targeting; Graphite Bio: SAB. MDM Astellas: Consultancy. No potential conflicts of interest are disclosed by the other authors.
